Updated regularly, the following posts spotlight trials of interest to cytokine researchers from ClinicalTrials.gov. The website, maintained by the National Library of Medicine (NLM), is an online database of clinical research studies and information about their results. It is provided as a place to learn about clinical studies from around the world.
Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections
ClinicalTrials.gov ID NCT06363370 Sponsor Kexing Biopharm Co., Ltd. Information provided by Kexing Biopharm Co., Ltd. (Responsible Party) Last Update Posted 2024-04-12 Brief Summary To evaluate the efficacy and safety of interferon α1b (GB05) in the treatment of children under 2 years of age with respiratory syncytial virus infection. Detailed Description...
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
ClinicalTrials.gov ID NCT06368882 Sponsor First Affiliated Hospital of Wenzhou Medical University Information provided by First Affiliated Hospital of Wenzhou Medical University (Responsible Party) Last Update Posted 2024-04-16 Brief Summary This is a prospective, multicenter, open-label, non-randomized controlled real-world study to explore the efficacy and safety and to accumulate more evidence-based...
[68Ga]Ga-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer Patients
ClinicalTrials.gov ID NCT06419361 Sponsor First Affiliated Hospital of Chongqing Medical University Information provided by Xiaoyang Zhang, First Affiliated Hospital of Chongqing Medical University (Responsible Party) Last Update Posted 2025-06-04 Brief Summary Stimulator of interferon gene (STING) protein plays a vital role in the immune surveillance of tumor microenvironment. Monitoring STING...
Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL (APL)
Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL (APL) ClinicalTrials.gov ID NCT06450145 Sponsor Zhejiang Provincial People’s Hospital Information provided by Zhejiang Provincial People’s Hospital (Responsible Party Brief Summary This study was a single-arm, open study. After the screening period, arsenic-resistant APL patients...
